March 21, 2018 Comments Off on Obstacles and opportunities in Chinese pharmaceutical innovation Posted in: Insights This article was originally published by Jingyun Ni, Junrui Zhao, Carolina Oi Lam Ung, Yuanjia Hu, Hao Hu and Yitao Wang in Globalization and Health201713:21 under a Creative Commons License. Abstract…
The post Obstacles and opportunities in Chin…
March 21, 2018 Comments Off on New patent expiration for Schering drug REBETOL Posted in: Uncategorized
Annual Drug Patent Expirations for REBETOL Rebetol is a drug marketed by Merck Sharp Dohme and Schering and is included in two NDAs. It is available from one supplier. There…
The post New patent expiration for Schering drug REBETOL appeared first…